SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

Read more breaking news

 

 
News in brief

FDA warns of fake Teva ADHD drug as shortage continues

30-May-2012

The FDA has warned patients about counterfeit versions of a Teva ADHD drug that is on the drug shortage list.

Lab tests run by the US Food and Drug Administration (FDA) show the Adderall (amphetamine and dextroamphetamine) bought online is devoid of the four official active pharmaceutical ingredients. Instead, the tablets contain tramadol and acetaminophen, APIs used in the treatment of acute pain.

API supply problems at Teva have put Adderall on the shortages list and the FDA says counterfeit drug producers may especially target treatments consumers are struggling to find legitimately. The FDA updated its shortages list two weeks ago to say Teva is still releasing Adderall when available.

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products

Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry
Need help to bring insoluble APIs to the market?
Dow Pharma & Food Solutions